文献速递创伤与烧伤重症综合管理与镇静镇痛

高渗乳酸钠减轻弥漫性创伤性脑损伤后功能缺陷:渗透或乳酸相关效应?

Hypertonic Sodium Lactate to Alleviate Functional Deficits Following Diffuse Traumatic Brain Injury: An Osmotic or a Lactate-Related Effect?
PubMed 文献 · Neurocrit Care · 2020-09-09
一句话结论大鼠创伤性脑损伤模型中,高渗乳酸钠与高渗盐水在神经认知测试表现上无差异,提示功能改善可能与血清渗透压升高有关,而非外源性乳酸补充。

该研究在impact-acceleration模型大鼠中比较了创伤后30分钟开始2小时输注等渗盐水、高渗乳酸钠(HSL)或等渗摩尔剂量高渗盐水(HSS)的效果,每组10只。与盐水组相比,HSL组在伤后第7天和第14天黏附去除测试完成潜伏期缩短,第7天放射臂迷宫测试完成时间缩短。但HSL组与HSS组在神经认知测试表现上无差异。HSL组和HSS组血清渗透压均高于盐水组,HSL组血清乳酸浓度高于盐水组和HSS组。作者认为HSL输注后认知和感觉运动测试的改善可能与血清渗透压升高有关,而非外源性乳酸补充。

要点

  • 大鼠TBI后30分钟开始2小时输注HSL,第7天黏附去除测试潜伏期中位数6秒(5-9) vs 盐水组13秒(8-17),第14天5秒(5-9) vs 11秒(8-26),P<0.05。
  • 第7天放射臂迷宫测试完成时间:HSL组99秒(73-134) vs 盐水组176秒(127-300),P<0.05。
  • HSL组与等渗摩尔HSS组在神经认知测试表现上无差异。
  • HSL组血清渗透压318 mOsm/Kg(315-321)和HSS组315 mOsm/Kg(313-316)均高于盐水组307 mOsm/Kg(305-309),P<0.05。
  • HSL组血清乳酸浓度6.4 mmol/L(5.3-7.2)高于盐水组1.5 mmol/L(1.1-1.9)和HSS组1.6 mmol/L(1.5-1.7),P<0.05。

适用人群与场景

  • 雄性大鼠,impact-acceleration模型造成弥漫性创伤性脑损伤,伤后30分钟开始输注。

处置流程与药物剂量

  • 伤后30分钟麻醉大鼠随机接受2小时输注等渗盐水(TBI-盐水组)或高渗乳酸钠(TBI-HSL组),每组10只。
  • 另一系列实验采用相似方案,比较等渗摩尔剂量的高渗乳酸钠和高渗盐水对TBI大鼠的效果,每组10只。
  • 输注2小时期间测量血乳酸和离子浓度。

研究设计与关键结果

  • 研究类型:动物实验(大鼠)。样本量:每组10只。人群:impact-acceleration模型弥漫性TBI大鼠。干预与对照:TBI-HSL组 vs TBI-盐水组;另一系列TBI-HSL组 vs TBI-HSS组。
  • 主要终点:黏附去除测试完成潜伏期,第7天TBI-HSL组中位数6秒(5-9) vs TBI-盐水组13秒(8-17),第14天5秒(5-9) vs 11秒(8-26),P<0.05。
  • 放射臂迷宫测试完成时间第7天:TBI-HSL组99秒(73-134) vs TBI-盐水组176秒(127-300),P<0.05。
  • TBI-HSL组与TBI-HSS组在神经认知测试表现上无差异。
  • 血清渗透压:TBI-HSL组318 mOsm/Kg(315-321)和TBI-HSS组315 mOsm/Kg(313-316) vs TBI-盐水组307 mOsm/Kg(305-309),P<0.05。
  • 血清乳酸浓度:TBI-HSL组6.4 mmol/L(5.3-7.2) vs TBI-盐水组1.5 mmol/L(1.1-1.9)和TBI-HSS组1.6 mmol/L(1.5-1.7),P<0.05。

证据类型、等级与局限

  • 证据类型:动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,TBI后输注HSL所见的认知和感觉运动测试改善可能与血清渗透压升高有关,而非外源性乳酸补充。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There has been growing interest in the use of hypertonic sodium lactate (HSL) solution following traumatic brain injury (TBI) in humans. However, little is known about the effects of HSL on functional deficits with respect to the hyperosmotic nature of HSL.

METHODS: We have compared the effects of HSL solution and isotonic saline solution using sensorimotor and cognitive tests for 14 days post-trauma in animals. Thirty minutes after trauma (impact-acceleration model), anesthetized rats were randomly allocated to receive a 2-h infusion of isotonic saline solution (TBI-saline group) or HSL (TBI-HSL group) (n = 10 rats per group). In another series of experiments using a similar protocol, the effects of equiosmolar doses of HSL and hypertonic saline solution (HSS) were compared in TBI rats (n = 10 rats per group). Blood lactate and ion concentrations were measured during the 2-h infusions.

RESULTS: Compared to the TBI-saline group, the TBI-HSL group had a reduced latency to complete the adhesive removal test: 6 s (5-9) (median [25-75th centiles]) versus 13 s (8-17) on day 7, and 5 s (5-9) versus 11 s (8-26) on day 14 (P < 0.05), respectively, and a shorter delay to complete the radial arm maze test on day 7: 99 s (73-134) versus 176 s (127-300), respectively (P < 0.05). However, no differences were found between the TBI-HSL and TBI-HSS groups in neurocognitive tests performance. Compared to the TBI-saline group, the HSL and HSS groups had higher serum osmolality: 318 mOsm/Kg (315-321) and 315 mOsm/Kg (313-316) versus 307 mOsm/Kg (305-309), respectively (P < 0.05), and the HSL group had a higher serum lactate concentration: 6.4 mmol/L (5.3-7.2) versus 1.5 mmol/L (1.1-1.9) and 1.6 mmol/L (1.5-1.7), respectively (P < 0.05).

CONCLUSIONS: These results indicate that improvements in cognitive and sensorimotor tests with HSL infusion post-TBI could be related to elevation of serum osmolality, not to exogenous administration of lactate.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Crespy T, Durost M, Fricault P, et al. Hypertonic Sodium Lactate to Alleviate Functional Deficits Following Diffuse Traumatic Brain Injury: An Osmotic or a Lactate-Related Effect? Neurocrit Care. 2020. PMID: 32901380. doi:10.1007/s12028-020-01090-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。